Hematology-Oncology Associates of the Quad-Cities, PC
Kidney Cancer Trials
CALGB 90802: A Phase III Trial Comparing Everolimus Plus Placebo Versus Everolimus Plus Bevacizumab For Advanced Renal Cell Carcinoma Progressing After Treatment With Tyrosine Kinase Inhibitors
